1980
DOI: 10.1042/bj1910533
|View full text |Cite
|
Sign up to set email alerts
|

Active-site modification of native and mutant forms of inosine 5′-monophosphate dehydrogenase from Escherichia coli K12

Abstract: IMP dehydrogenase of Escherichia coli was irreversibly inactivated by Cl-IMP (6-chloro-9-beta-d-ribofuranosylpurine 5'-phosphate, 6-chloropurine ribotide). The inactivation reaction showed saturation kinetics. 6-Chloropurine riboside did not inactivate the enzyme. Inactivation by Cl-IMP was retarded by ligands that bind at the IMP-binding site. Their effectiveness was IMP>XMP>GMP>>AMP. NAD(+) did not protect the enzyme from modification. Inactivation of IMP dehydrogenase was accompanied by a change in lambda(m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
22
0

Year Published

1981
1981
2011
2011

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(25 citation statements)
references
References 14 publications
3
22
0
Order By: Relevance
“…IMPDH, encoded by the guaB gene catalyses the reversible conversion of IMP to XMP. In E. coli, at least two different enzymic pathways lead to the synthesis of XMP (Neuhard & Nygaard, 1996;Pimkin et al, 2009) which are well characterized (Gilbert et al, 1979;Gilbert & Drabble, 1980;Kerr & Hedstrom, 1997;Kerr et al, 2000;Tiedeman & Smith, 1985). However, the M. tuberculosis H37Rv purine de novo biosynthesis pathway enzymes have received little attention to date and are poorly studied.…”
Section: Discussionmentioning
confidence: 99%
“…IMPDH, encoded by the guaB gene catalyses the reversible conversion of IMP to XMP. In E. coli, at least two different enzymic pathways lead to the synthesis of XMP (Neuhard & Nygaard, 1996;Pimkin et al, 2009) which are well characterized (Gilbert et al, 1979;Gilbert & Drabble, 1980;Kerr & Hedstrom, 1997;Kerr et al, 2000;Tiedeman & Smith, 1985). However, the M. tuberculosis H37Rv purine de novo biosynthesis pathway enzymes have received little attention to date and are poorly studied.…”
Section: Discussionmentioning
confidence: 99%
“…Reagents such as iodoacetamide and methylmethanethiosulphonate inactivate IMPDH. IMP protects against inactivation, which provided the first evidence that a Cys residue might be present in the active site 71,92. Surprisingly given the position of IMPDH at the junction of guanine nucleotide metabolism, no allosteric regulators have been identified for IMPDH (reports that ATP is an allosteric regulator have not been confirmed 5,63,79).…”
Section: Purification and Characterizationmentioning
confidence: 99%
“…However, the catalytic Cys can also provide specificity. Several analogs of IMP have been designed to form covalent adducts with this residue, including 6-Cl-IMP, EICARMP, 2-Cl-methyl-IMP, 6-thio-IMP and 2-vinyl-IMP, 2-F-vinyl-IMP (Chart 11) 92,113,252-256. All of these compounds are time-dependent irreversible inactivators of IMPDH.…”
Section: Inhibitors Of Impdhmentioning
confidence: 99%
“…The degree of sensitivity exhibited by UCA synthase to these reagents is much lower than that of the IMP dehydrogenases. Both the human and E. coli IMP dehydrogenases, for example, are rapidly inactivated by iodoacetamide (1,6). In contrast, UCA synthase retains 87% of its activity after exposure to iodoacetamide for a period of 6 h. On the other hand, UCA synthase is completely inactivated by a 15-min exposure to p-HMB or mercuric chloride.…”
Section: Discussionmentioning
confidence: 88%
“…This result indicates that one or more thiol groups are necessary for the activity of the enzyme. The affinity reagent 6-chloro-IMP has been reported to rapidly inactivate the E. coli (6), human (1), and T. foetus IMP dehydrogenases (13). The inactivated E. coli enzyme could be quickly reactivated by incubation with 2-mercaptoethanol, and an active-site cysteine residue was implicated as the target of the 6-chloro-IMP.…”
Section: Discussionmentioning
confidence: 95%